News
Delta-9-Tetrahydrocannabinol Modulates Pain Sensitivity Among People Receiving Opioid Agonist Therapy
Joao De Aquino, MD, assistant professor of psychiatry, and Mehmet Sofuoglu, MD, PhD, professor of psychiatry, are first and senior authors, respectively, of a study in Addiction Biology that studies the acute effects of the delta-9-tetrahydrocannabinol among people receiving methadone therapy for opioid use disorder.
Source: Addiction Biology